Tag:
Embeda
Latest Headlines
Latest Headlines
Pfizer yanks one of its new pain pills from King
Pfizer’s newly acquired King Pharmaceuticals is recalling its painkiller Embeda for the fourth time in a little more than a year. And a Pfizer spokesperson told Reuters that it may be off the
FDA approves King's 'abuse-resistant' painkiller
Shares of King Pharmaceuticals surged on the news that the FDA has approved Embeda, a new painkiller that's designed to limit abuse by people looking for a quick high. King researchers added an
King wins approval for anti-abuse painkiller Embeda
Even after several rejections, King Pharma held its ground in its push for Alpharma--and its persistence has paid off. Under the $1.6 billion merger agreement, King got its hands on Alpharma's
FDA: Embeda could carry abuse risk
FDA staffers have expressed concern that Alpharma's powerful painkiller Embeda could be abused even though the company designed the drug not to be. Embeda contains morphine sulfate and Duramorph.
Alpharma's Embeda relieves pain in Phase III
Alpharma's abuse-resistant pain drug effectively prevented pain in osteoarthritis patients with moderate to severe pain. More than 72 percent of Embeda (ALO-01) patients said they experienced at
Alpharma withdraws painkiller NDA
Alpharma has withdrawn its NDA for Embeda, its extended-release painkiller. While the company's drug qualified for priority review, Alpharma said that "certain technical issues around data
